Selected article for: "cell culture and enzymatic activity"
Author: Liu, Pan; Xie, Xinfang; Gao, Li; Jin, Jing
Title: Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects
  • Cord-id: 50crj02y
  • Document date: 2020_10_17
    • ID: 50crj02y
    Snippet: Angiotensin-converting enzyme 2 (ACE2) is the entry receptor for SARS-CoV-2, and recombinant ACE2 decoys are being evaluated as new antiviral therapies. We designed and tested an antibody-like ACE2-Fc fusion protein, which has the benefit of long pharmacological half-life and the potential to facilitate immune clearance of the virus. Out of a concern that the intrinsic catalytic activity of ACE2 may unintentionally alter the balance of its hormonal substrates and cause adverse cardiovascular eff
    Document: Angiotensin-converting enzyme 2 (ACE2) is the entry receptor for SARS-CoV-2, and recombinant ACE2 decoys are being evaluated as new antiviral therapies. We designed and tested an antibody-like ACE2-Fc fusion protein, which has the benefit of long pharmacological half-life and the potential to facilitate immune clearance of the virus. Out of a concern that the intrinsic catalytic activity of ACE2 may unintentionally alter the balance of its hormonal substrates and cause adverse cardiovascular effects in treatment, we performed a mutagenesis screening for inactivating the enzyme. Three mutants, R273A, H378A and E402A, completely lost their enzymatic activity for either surrogate or physiological substrates. All of them remained capable of binding SARS-CoV-2 and could suppress the transduction of a pseudotyped virus in cell culture. This study established new ACE2-Fc candidates as antiviral treatment for SARS-CoV-2 without potentially harmful side effects from ACE2's catalytic actions toward its vasoactive substrates.

    Search related documents:
    Co phrase search for related documents
    • activity loss and luciferase reporter: 1, 2, 3
    • activity loss and luciferase reporter gene: 1
    • acute ards respiratory distress syndrome and additional function: 1
    • acute ards respiratory distress syndrome and low affinity: 1
    • acute ards respiratory distress syndrome and luciferase activity: 1, 2
    • acute ards respiratory distress syndrome and luciferase reporter: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and luciferase reporter gene: 1
    • additional function and luciferase activity: 1, 2
    • additional function and luciferase reporter: 1, 2
    • low affinity and luciferase reporter: 1